Research graph
References from FACTORS ASSOCIATED WITH PERSISTENT VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND NONPROLIFERATIVE DIABETIC RETINOPATHY AFTER LOST-TO-FOLLOW-UP. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
10.1186/s40662-015-0026-2 · 2015 · External reference
Trends in prevalence and treatment of diabetic macular edema and vision-threatening diabetic retinopathy among medicare part B fee-for-service beneficiaries
10.1001/jamaophthalmol.2022.0052 · 2022 · External reference
Twenty-year trends in prevalence and incidence of diabetic retinal disease
10.1016/j.ophtha.2025.01.022 · 2025 · External reference
Real-world outcomes of anti–vascular endothelial growth factor therapy in diabetic macular edema in the United States
10.1016/j.oret.2018.06.004 · 2018 · External reference
Compliance and adherence of patients with diabetic macular edema to intravitreal anti–vascular endothelial growth factor therapy in daily practice
10.1097/iae.0000000000001892 · 2018 · External reference
Appointment compliance in patients with diabetic macular edema and exudative macular degeneration
10.3928/23258160-20180221-06 · 2018 · External reference
The short-term effect of a single lapse in anti–vascular endothelial growth factor treatment for diabetic macular edema within routine clinical practice
10.1016/j.ajo.2020.06.040 · 2020 · External reference
Outcomes of eyes with diabetic macular edema that are lost to follow-up after anti–vascular endothelial growth factor therapy
10.1016/j.ajo.2021.06.028 · 2022 · External reference
Lapses in care among patients assigned to ranibizumab for proliferative diabetic retinopathy: a post hoc analysis of a randomized clinical trial
10.1001/jamaophthalmol.2021.4103 · 2021 · External reference
Predictors of vision loss after lapse in antivascular endothelial growth factor treatment in patients with diabetic macular edema
10.1177/24741264241305123 · 2025 · External reference
Loss to follow-up after intravitreal anti–vascular endothelial growth factor injections in patients with diabetic macular edema
10.1016/j.oret.2018.11.002 · 2019 · External reference
Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes
10.2337/diacare.22.5.779 · 1999 · External reference
Causes of blindness and visual impairment in a population of older Americans: the Salisbury eye evaluation study
10.1001/archopht.118.6.819 · 2000 · External reference
Monitoring visual status: why patients do or do not comply with practice guidelines
10.1111/j.1475-6773.2004.00297.x · 2004 · External reference
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study
10.1016/j.ophtha.2004.03.002 · 2004 · External reference
Place, race, and lapses in diabetic retinopathy care
10.1001/jamaophthalmol.2024.0974 · 2024 · External reference
Health disparities in lapses in diabetic retinopathy care
10.1016/j.xops.2023.100295 · 2023 · External reference
Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections
10.1016/j.ophtha.2018.02.034 · 2018 · External reference
Blindness caused by diabetic retinopathy
10.1016/0002-9394(74)90010-5 · 1974 · External reference
Race/ethnic difference in diabetes and diabetic complications
10.1007/s11892-013-0421-9 · 2013 · External reference
